GeoVax Labs, Inc. (GOVX)

0.2985 -0.03 (-10.39%) USD  |  NASDAQ  |  Dec 16, 13:45
More

GeoVax Labs Research and Development Expense (Quarterly): 5.044M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for GOVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Omeros Corp. 15.76M
Vistagen Therapeutics, Inc. 15.86M
Daré Bioscience, Inc. 0.6933M
Jaguar Health, Inc. 3.658M
Spero Therapeutics, Inc. 8.597M